Lv5
1110 积分 2023-11-20 加入
Novel LC-MS/MS analysis of the GLP-1 analog semaglutide with its application to pharmacokinetics and brain distribution studies in rats
2天前
已完结
Antidiabetic agents as a novel treatment for Alzheimer’s and Parkinson’s disease
3天前
已完结
Beyond fat: Does semaglutide affect lean mass?
15天前
已完结
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
1个月前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
1个月前
已完结
Amylin - an anorexigenic pancreas-brain signal
1个月前
已关闭
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
2个月前
已完结
The elusive role of myostatin signaling for muscle regeneration and maintenance of muscle and bone homeostasis
2个月前
已完结
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
2个月前
已完结
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
2个月前
已完结